Table of Contents

Oral presentations

[O01-1] Attitudes and implementation of shared decision making: the practicalities of consumer involvement among patients with chronic diseases Abstract
C Renzi, S Mastroeni, V Salvatori, N Melo Salcedo, S Tortora, E Mazzotti, T J Mannooranparampil, P Pasquini
[O01-2] Prioritizing clinical research together with patients’ associations: early steps from the PartecipaSalute project Abstract
C Colombo, R Satolli, A Liberati, P Mosconi
[O01-3] Plain language summary format for Cochrane reviews: results of user testing Abstract
N Santesso, C Glenton, ES Nilsen, S Rosenbaum, T Rader, J Pardo, A Ciapponi, S Hill, R Ryan, H Dilkes
[O01-4] Evaluation of a web-based interactive patient information (‘patient dialogue’) to enhance shared decision making Abstract
D Simon, C Vietor, A Loh, T Hecke, M Härter
[O02-5] Comparison of descriptions of blinding in trial protocols and the published reports Abstract
A Hróbjartsson, J Pildal, A-W Chan, MT Haahr, DG Altman, PC Gøtzsche
[O02-6] Empirical evidence of bias: modified intention to treat analysis of randomised trials affects estimates of intervention efficacy Abstract
I Abraha, PG Duca, A Montedori
[O02-7] Empirical evidence of attrition bias in meta-analyses of randomized controlled trials Abstract
E Nüesch, S Trelle, S Reichenbach, A Rutjes, M Scherrer, E Bürgi, P Jüni
[O02-8] Empirical investigation of optimism bias Abstract
B Djulbegovic, A Magazin, A Kumar, H Soares, I Hozo, M Schell
[O03-9] Study design features affect estimates of sensitivity and specificity, but effects may vary Abstract
AWS Rutjes, N Smidt, M Di Nisio, JG Lijmer, BWJ Mol, JC Van Rijn, PMM Bossuyt, JB Reitsma
[O03-10] Can diagnostic filters offer similar sensitivity and a reduced number needed to read compared to searches based on index test and target condition? Abstract
PF Whiting, ME Westwood, M Burke, JAC Sterne, J Glanville
[O03-11] Which meta-analysis model best fits my diagnostic test data? Use of model fit statistics Abstract images
N Novielli, NJ Cooper, AJ Sutton, KR Abrams
[O03-12] Adapting diagnostic review methods to summarise the properties of psychometric instruments: a case study of diagnosing postnatal depression (PND) in primary care Abstract
C Hewitt, R Mann, S Gilbody
[O04-13] Exploring the geometry of treatment networks Abstract
G Salanti, FK Kavvoura, JPA Ioannidis
[O04-14] Assessment of methods to adjust for publication bias through a comprehensive simulation study Abstract
SG Moreno, AJ Sutton, AE Ades, TD Stanley, KR Abrams, JL Peters, NJ Cooper
[O04-15] Cluster randomised trials produced similar results to individually randomised trials in a meta-analysis of enhanced care for depression Abstract
S Gilbody, D Torgerson, P Bower, D Richards
[O04-16] Indirect comparisons for evaluating healthcare interventions: review of published systematic reviews and discussion of methodological problems Abstract
FJ Song, YK Yoon, T Walsh, AM Glenny, AJ Eastwood, DG Altman
[O05-17] Challenges of developing a geographic search filter to identify randomized controlled trials in Africa: finding the optimal balance between sensitivity and precision Abstract images
E Pienaar, L Grobler, N Siegfried, A Eisinga
[O05-18] Development of a methodological PubMed search filter for finding studies on measurement properties of outcome measures Abstract
CB Terwee, AP Jansma, I Riphagen, HCW De Vet
[O05-19] How and where to search for secondary evidence on ‘upstream’ interventions for public health problems: a case study Abstract
J Woodman, T Lorenc, C Stansfield, A Harden, A Oakley, H Roberts, J Kavanagh
[O05-20] The availability and usefulness of FDA documents for conducting systematic reviews Abstract images
S Carson, MS McDonagh
[O06-21] Implementation and impact of reviews Cochrane reviews: are they as useful as we would like to think? Abstract
M Westby, I Bullock
[O06-22] Cochrane versus non-Cochrane reviews: an exploration of discordance, comparative quality and relevance for patient information Abstract
H Bastian, M Knelangen, S Lange, M Nasser
[O06-23] How many guidelines are developed by evidence-based methods in Korea? Evaluation of 54 guidelines developed by Korean specialty societies Abstract
H Ahn, H Kim, M Kyung, S Lee
[O06-24] Analysis of the level of evidence included in the recommendations given during health-based news reports on Brazilian television Abstract
VP Vieira, RB Andriolo, LG Lima, CR Macedo, ME Puga, R Riera, BN Silva, AN Atallah
[O07-25] Summaries of evidence for health policymakers in low and middle income countries (LMIC) Abstract
S Rosenbaum, C Glenton, AD Oxman
[O07-26] A systematic method of identifying and prioritising research questions Abstract
O Clavisi, R Gruen, P Bragge, E Tavender
[O07-27] Do Cochrane systematic reviews help decision makers from middle income countries? Update of the Chilean experience Abstract
G Rada, D Capurro, T Pantoja, LM Letelier, G Moreno
[O07-28] Expanding the production and use of systematic reviews: the centres for systematic reviews of health policy and systems research in low- and middle-income countries Abstract
T Pantoja, T Pe rez Koehlmoos, G Pariyo, S Bennett, A Oxman, S Oliver, P Garner
[O08-29] Trends in randomized controlled trials of malaria treatment and prophylaxis in Africa Abstract images
V Lutje, L Grober, P Garner, N Siegfried
[O08-30] Repurposing Cochrane reviews for a community health information project in Sierra Leone: Malaria prevention Abstract
A Weightman, LN M’Jamtu-Sie, GN Gage, VO Cole, LS Godbolt
[O08-31] Costs and cost-outcomes of school feeding programs in Africa Abstract
E Kristjansson, R Galloway, A Gelli, U Meir, D Bundy, F Espejo
[O08-32] Evaluating Evidence Aid Abstract
T Turner, M Clarke, S Green, P Tharyan, P Lumbiganon, P Garner, H Smith, K Clark
[O09-33] Development of a tool to evaluate the quality of observational studies Abstract
N Berkman, M Viswanathan
[O09-34] Impact of funding source on reporting of adverse effects: methodological overview Abstract
S Golder, YK Loke, J Burch
[O09-35] Why don’t GPs follow guidelines? Increasing our understanding of complex interventions by combining qualitative and quantitative reviews Abstract
C Glenton, B Carlsen, M Eccles, J Francis, J Grimshaw, C Pope
[O10-36] Expressing meta-analyses of continuous outcomes in terms of risks Abstract
J Anzures, J Higgins
[O10-37] Heterogeneity in meta-analysis: misconceiving I² Abstract
G Rücker, G Schwarzer, M Schumacher
[O10-38] How meta-analytical inferences in practice depend on the choice of between-trial variance estimator Abstract
K Thorlund, C Gluud, J Wetterslev
[O10-39] Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: application to stroke prevention treatments for Atrial Fibrillation patients Abstract
NJ Cooper, AJ Sutton, AE Ades, NJ Welton
[O11-40] Internet-based data management tool for systematic reviews Abstract
S Trelle, M Kjeldstrom, A Reichenbach, P Jüni
[O11-41] Streamlining meta-analysis processes through the integrated use of a computational ontology and statistical language Abstract
R Pietrobon, A Shah, C Cook, J Shah, S Tan, E Chan
[O11-42] Deja vu: a new database tool complementing systematic reviews in detecting duplicate publications Abstract
RP Dellavalle, JD Wren, HC Williams
[O11-43] Evidence-based decision support in practice for quality improvement: an international collaboration experience Abstract
I Kunnamo, K Moidu, P Nyberg, S Margolis, R Schooler, T Kortteisto, M Kaila, S Tirmizi
[O12-44] Comparison of methods of grading bodies of evidence and strength of recommendations used by clinical practice guideline groups Abstract
S Norris
[O12-45] Are Cochrane systematic reviews being used in national clinical practice guidelines for chronic kidney disease? Abstract
A Tong, D Campbell, RG Walker, JC Craig
[O12-46] The use of Cochrane Reviews in practice guidelines for Dutch GPs Abstract
AN Bastick, AN Goudswaard, TJ Wiersma, JC Van Der Wouden
[O12-47] Preventing infections in cancer patients: what influences the guidelines? Abstract
C Herbst, I Monsef, F Naumann, J Bohlius, A Engert
[O13-48] The Cochrane Updating Project Abstract
J Brown, A Lethaby, J Clarke, V Jordan, M Showell, C Farquhar
[O13-49] Development of a decision tool for updating Cochrane reviews Abstract
S Hopewell, K Loudon, M Clarke, D Moher, S French, R Scholten, A Eisinga
[O13-50] Evidence-based priority-setting for new systematic reviews: a case study for primary open-angle glaucoma Abstract images
T Li, K Dickersin, E Ssemanda, R Scherer, A Ervin
[O13-51] The ‘What’s new’ section in Cochrane reviews updated in 2007 Abstract
K Loudon, S Hopewell
[O14-52] How many false ‘RCTs’ were included in Cochrane systematic reviews of Traditional Chinese Medicine? Abstract
W Taixiang, Y Xunzhe, Z Xiaoxi, Z Qi, Y Yong, L Qifu, W Phil
[O14-53] The prevalence of outcome reporting bias in trials (the ORBITstudy) Abstract
J Kirkham, D Altman, S Dodd, K Dwan, C Gamble, A Jacoby, S Taylor, P Williamson
[O14-54] The ORBIT Study: outcome reporting bias in trials – interviews with trialists who do and do not report all outcomes Abstract
RMC Smyth, A Jacoby, C Gamble, D Altman, J Kirkham, P Williamson
[O14-55] The SPIRIT initiative: defining standard protocol items for randomised trials Abstract
A Chan, J Tetzlaff, DG Altman, PC Gøtzsche, A Hrobjartsson, K Krlezˇ a-Jeric, A Laupacis, D Moher
[O15-56] The accuracy of anti-CCP antibodies for the diagnosis of rheumatoid arthritis: a systematic review Abstract images
N Smidt, P Whiting, R Harbord, M Burke, P Dieppe, J Sterne
[O15-57] Meta-analysis of diagnostic test studies using individual patient data and aggregate data Abstract
RD Riley, SR Dodd, JV Craig, PR Williamson
[O15-58] The efficacy of non-nicotine smoking cessation drugs: a mixed treatment comparison Abstract
N Chaiyakunapruk, W Hora, J Jumpahom, K Jampachaisri, I Sakunrak
[O15-59] Using mixed-effects meta-analysis to examine the impact of study design, patient characteristics, and treatment intensity in a systematic review of music therapy for serious mental disorders Abstract
C Gold, HP Solli, V Krüger, SA Lie
[O16-60] Risk of bias versus quality: application and recommendations for the Cochrane ‘Risk of bias’ tool Abstract
L Hartling, M Ospina, Y Liang, DM Dryden, TP Klassen
[O16-61] The association of three bias domains with treatment effect estimates in randomised control trials: combined analysis of meta-epidemiological studies Abstract images
J Savovic, RJ Harris, The Brando Collaborators
[O16-62] Endpoints of meta-analyses and primary endpoints of included studies: impact of non-concordance Abstract
C Lerch, B Richter
[O16-63] Small sample size, composite endpoints, trials stopped early for benefit: threats to valid meta-analysis Abstract
G Guyatt, PJ Devereaux, S Yusuf, H Yang, P Alonso-Coello, A Ciapponi, J Pogue, A Salazars, M Tristan, G Urrutia
[O17-64] Education and training Assessment of ‘Understanding evidence-based health care’: a foundation for action, an online course for consumer advocates Abstract
M Mayer, K Dickersin, C Costantino, M Hamilton, B Warren, D Werapitya
[O17-65] The James Lind Library: a free, multilingual web-based resource for public and professional education Abstract
I Chalmers, I Milne, U Troehler, J Vandenbroucke, A Morabia, G Tait, E Dukan
[O17-66] Supporting evidence-based practice and Cochrane reviews: the SEA-ORCHID fellowships programme Abstract
P Pattanittum, J Short, T Turner, R Martis, S McDonald
[O17-67] The analyses of the differences between physicians and nurses in evidence-based medicine Abstract
KN Kuo, YH Weng, YWB Chiu, HL Lo, HW Ting
[O18-68] Language and geographical differences in the access to Cochrane reviews Abstract
M Roque
[O18-69] First province in Canada to provide access to The Cochrane Library: lessons learned Abstract
D Forbes, C Neilson, J Bangma, J Forbes, D Fuller
[O18-70] Development and evaluation of ‘Summary of findings’ tables for Cochrane reviews Abstract
S Rosenbaum, C Glenton, HK Nylund, AD Oxman
[O18-71] Inadequate descriptions of treatments in published reports: a common but correctable barrier to new effective interventions Abstract
P Glasziou, E Meats, C Heneghan, S Shepperd
[O19-72] Economic analyses are necessary to guide incorporation of new drugs to clinical practice in the treatment of breast cancer Abstract images
A Sasse, P Pinto
[O19-73] Comparison of methods to evaluate the quality of evidence in resource studies: a pilot study Abstract
M Brunetti, A Pregno, AD Oxman, A Liberati
[O19-74] Bayesian mixed treatment comparison meta-analysis of interventions for Metabolic Syndrome Abstract images
M Castro, K Charles, A Dunkley, K Abrams, K Khunti
[O19-75] Publication of economic evaluations alongside clinical trials: preliminary evidence of bias Abstract
S Gilbody, A Sutton, P Bower

Poster presentations

[P01-1] What’s the problem in involving consumers in Cochrane review groups: the experiences of the consumer representative on the Monitoring and Registration Group Abstract
M Zhang
[P01-2] Barriers and concerns in patient perceptions of shared decision making in China Abstract
MM Zhang, GJ Liu, HQ Wang, XY Chen, QW Zhang, F Wang, ZY Fan, Y Zhou
[P01-3] Clinician’s basic knowledge on patient safety in China Abstract
XY Chen, ZY Fan, Y Zhou, XX Dong, Y Liu, XL Wan, F Wang, QW Zhang
[P01-4] A survey analysis of doctors’ perceptions of difficulties in patient involvement in clinical decision making Abstract
QW Zhang, XY Chen, F Wang, ZY Fan, Y Zhou, Y Liu, HQ Wang, XX Dong
[P01-5] Database of patients’ organizations in Latin America & the Caribbean Abstract
A Ciapponi, C Cattivera, A Esperato Martinez, B Nieto Pereda, J Gonseth-Garcı´a
[P01-6] The impact of shared decision making on patient satisfaction in German primary care Abstract
L Hölzel, L Kriston, M Härter
[P01-7] The Cochrane Library as a basic source for development of EBM guidelines for people living with HIV/AIDS: Russian experience Abstract
N Kryuchkov, K Danishevskiy, V Vlassov, V Rafalskiy, A Gill
[P02-8] Funding sources of the trials included in Cochrane reviews: pros and cons of disclosure in the abstract and plain language summary Abstract
M Napoli, J Wale
[P02-9] Ten years of The Cochrane Drugs and Alcohol Group: challenges for primary research Abstract
L Amato, M Davoli, Cochrane Drugs and Alcohol Group
[P02-10] Engaging stakeholders to improve the understanding and use of Cochrane reviews Abstract
C Arratoon, M Schaafsma
[P02-11] Prioritisation of Cochrane reviews for consumers and the public to promote evidence-based health care Abstract
M Belizan, S Vij, J Wale, A Zelmer, L Whamond
[P02-12] Open access for best evidence in the era of globalization Abstract
Y Chen, L Du, C Ai, Y Li
[P02-13] Evidence for improving communication and participation: evaluation of Evidence Bulletin knowledge transfer Abstract
H Dilkes, S Hill, R Ryan
[P02-14] Journal of Evidence-based Medicine: a new window to introduce best evidence from China Abstract
L Du, Y Chen, X Diao, M Chen, Y Li
[P02-15] Italian Cochrane Centre educational and disseminative activities Abstract
V Sala, L Moja, I Moschetti, V Pistotti, R Banzi, E Parmelli, M Cinquini, A Liberati
[P02-16] Delivering on priorities: developing and implementing effective collaboration between a Cochrane Review Group (CRG) and a Cochrane Field Abstract
L Elstub, H Handoll, D Stott, R Madhok, J Elliott, G Ramirez
[P02-17] Online information portal for evidence-based research on anxiety and trauma-related disorders Abstract
J Ipser, DJ Stein, L Hoppe
[P02-18] Integrating context into health technology assessment and knowledge transfer Abstract
K Gartenburg, C Larsen, H Noorani
[P03-19] Individual drug reviews, class reviews and multiple-treatments meta-analyses: in the case of new generation antidepressants and antipsychotics Abstract
TA Furukawa, A Cipriani, C Barbui, N Watanabe, I Omori, H McGuire, R Churchill, G Salanti
[P03-20] Quality of evidence informing clinical guidelines on treatment of opioid dependence Abstract
M Davoli, L Amato, S Hill, S Minozzi, N Clark, V Poznyak
[P03-21] Implementation of the GRADE method for developing recommendations on the use of insulin analogues for the management of diabetes mellitus Abstract
H Bennett, S Singh
[P03-22] Systematic review of evidence grading systems for grading levels of evidence Abstract
V Shukla, A Bai, S Milne, G Wells
[P03-23] Understanding clinicians’ perceptions of, endorsements of, and intentions to use cancer practice guidelines Abstract
M Brouwers, S Hanna, M Abdel-Montagally, J Yee
[P03-24] Use of systematic reviews in clinical practice guidelines developed by the Brazilian Medical Association Abstract
C Nascente, A Sasse
[P03-25] Methylxanthines for apnea of prematurity: is a broad systematic review needed? Abstract images
D Bassler, A Bialkowski, A Ohlsson, C Poets, R Roberts, B Schmidt
[P03-26] Dementia guidelines in Europe: the EuroCoDe database and consensus guideline Abstract
H Collins, A Kerr
[P03-27] Effectiveness of herbal medicine for acute stroke: an overview of the Cochrane systematic reviews Abstract
X Chen, Z Zhao, T Wu
[P03-28] Formalising the use of evidence synthesis to designing future research coherently and efficiently: a framework proposal Abstract images
AJ Sutton, NJ Cooper, DR Jones
[P03-29] Quality improvement in the care of depressive disorders: transfer of evaluated quality management practice tools into routine Abstract
FL Komarahadi, I Bermejo, A Peetz, O Borgert, M Härter
[P03-30] How do clinicians decide on appropriate treatment when there is a lack of high level evidence? Abstract
M Mahdian, M Nasser, Z Fedorowicz
[P04-31] Updating Cochrane reviews: vigilance required? Abstract
KJ Ward, FC Taylor, E Bickerdike, S Ebrahim
[P04-32] Journal editors’ views on publication ethics: results of an international survey Abstract
S Fiack, L Wager
:[P04-33] A collaboration-wide survey of Cochrane authors Abstract
D Gillies, H Maxwell, K New, V Pennick, Z Fedorowicz, J Van Der Wouden, J Oliver, R. Scholten, A Ciapponi, J Verbeek
[P04-34] Low quality of reporting of primary outcomes in Cochrane abstracts Abstract
V Vlassov
[P04-35] Gynaecological Cancer Group - NHS Cochrane Collaboration Programme Grant Scheme Abstract
C Williams, C Jess, G Quinn, A Oestmann, HO Dickinson, A Bryant
[P05-36] Education and training issues Improving support and raising standards: a pilot induction and mentoring programme for new Review Group Co-ordinators in The Cochrane Collaboration Abstract
M Prictor, J Cracknell, V Pennick, J Thomas
[P05-37] Knowledge, attitude and practices of evidence-based medicine among doctors in selected hospitals in Sri Lanka Abstract
C Abeysena, P Jayawardana, R Wickremasinghe, U Wickramasinghe
[P05-38] Evidence-based medicine teaching in Brazilian medical schools Abstract
MES Puga, RB Andriolo, LGS Lima, CR Macedo, R Riera, BNG Silva, VP Vieira, AN Atallah
[P05-39] The development of evidence-based medicine in traditional Chinese medicine Abstract
Z Junhua, S Hongcai, Z Boli, W Taixiang, G Xiumei, Y An
[P05-40] Improving knowledge on evidence-based health care (EBHC) in a middle-income country with short courses Abstract
L Letelier, C Herrera, C Zavala, S Rivera, A Riquelme, O Padilla
[P05-41] EBM education situation in China Abstract images
Y Yuan, X Zeng, T Wu
[P05-42] Education and support for improving the evaluation of consumer participation in hospitals: content, process and research capacity Abstract
S Hill, H Dilkes
[P05-43] Reviews for Africa Programme: what 3 years of RAPping can do for you! Abstract
T Young, H Maclehose, J Volmink, P Garner, N Siegfried
[P05-44] Developing evidence-based practice skills in the public health workforce Abstract
P Baker, R Armstrong, D Francis, E Smith
[P05-45] Effect of involving undergraduates in EBM practices on improving their abilities Abstract
J Huang, L Du, M Chen, Y Li
[P05-46] Effects of changes in the pre-licensure education of health workers Abstract
GW Pariyo, SN Kiwanuka, E Rutebemberwa, F Ssengooba, O Okui
[P05-47] Statistical literacy in health in a highly motivated patient sample Abstract
W Gaissmaier, G Gigerenzer, B Silberhorn
[P05-48] Scoping exercise to map training materials currently available to support review authors Abstract
A Dewey, A Drahota, D Gal, T Dean
[P05-49] Helping doctors to understand screening tests Abstract
G Gigerenzer
[P05-50] Predictors of evidence-based knowledge in Italian doctors Abstract
M Cinquini, L Moja, I Moschetti, V Sala, V Torri, A Liberati
[P05-51] Evidence production and dissemination in Iran: the Iranian Cochrane Informal Network (ICInet) Abstract
M Nasser, Z Ahangari, B Houshmand, M Khoshnevisan, H Javaheri, K Yassiny, S Hajebrahimi, N Shakhssalim
[P05-52] Information literacy and technologies for promoting the evidence: a Cuban experience Abstract
A Torres Pombert
[P06-53] Implementation and impact of reviews To randomise or not to randomise: a matter of perspective? Abstract
M Rodgers, D Chambers, N Woolacott
[P06-54] Panoramic overview of systematic reviews in oral health Abstract
M Nasser, JC Türp, G Antes
[P06-55] Empirical evaluation of a methodology for determining when a comparative drug effectiveness review has become out-of-date Abstract
K Peterson, BK Chan, MS McDonagh
[P06-56] Frequency of Cochrane systematic review in dentistry guidelines Abstract
CR Macedo, R Riera, RB Andriolo, BNG Silva, LGS Lima, MES Puga, VP Vieira, AN Atallah
[P06-57] Severe sepsis: how many guidelines have been including Cochrane systematic reviews? Abstract
BNG Silva, RB Andriolo, LGS Lima, MES Puga, R Riera, CR Macedo, VP Vieira, AN Atallah
[P06-58] Evidence-based quality indicators of obstetric care Abstract
MB Aller, D Rigau, M Roque´ Fı´guls, I Sola`, X Bonfill
[P06-59] What will the first impact factor of The Cochrane Library tell us Abstract
I Craig
[P06-60] The impact of utilizing implications for practice in Cochrane systematic reviews on patient care in obstetrics Abstract
A Nabhan
[P06-61] Integrating systematic review findings through risk stratification: the case of heart failure management Abstract
DH Smith, ES Johnson, ML Thorp, X Yang, AF Petrik, KA Crispell
[P06-62] Implementation of evidence-based practice at a regional hospital in Abstract
U Swadpanich, T Siriwachirachai, P Lumbiganon, M Laopaiboon
[P06-63] Normative and empirical issues in evidence-based recommendations Abstract
C Muth, M Beyer, J Gensichen, F M Gerlach
[P07-64] Information technology (web 2.0, software issues, internal communication) Quit the chaos: development of a tool to organise two or more reviewers in the assessment process easily Abstract
I Wilbacher, G Endel, I Schiller-Fruehwirth
[P07-65] The E-trials project: first steps in the development of a study-based eyes and vision trials database Abstract images
E Ssemanda, K Dickersin, T Li, R Scherer, A Ervin, B Hawkins
[P07-66] The Brazilian Cochrane Centre’s contribution to decision making in the public health system Abstract
BN Silva, AN Atallah
[P07-67] How ‘evidence-based’ is Wikipedia? Abstract
IQWIG NDI Working Group
[P08-68] Methodological limitations in the trials of iron supplementation for iron deficiency anemia (IDA) in children Abstract
X Zeng, T Hu, Y Yuan, T Wu
[P08-69] Effect of allocation concealment and examiner masking on magnitude of clinical outcomes Abstract
J Fenwick, I Needleman, D Moles
[P08-70] Intervention bias: presence and impact in trials of socially-complex health care interventions Abstract
B Lindsay
[P08-71] Does St. John’s wort work better in German-speaking countries? A meta-regression analysis investigating the influence of country of origin on study results Abstract
K Linde, L Kriston, M Berner
[P08-72] Health related quality of life in ovarian carcinoma: methodological issues in randomised controlled trials Abstract
C Main, T Moxham, K Stein
[P08-73] Assessing risk of bias: comparison of the PEDro scale with Cochrane’s ‘Risk of bias’ tool Abstract
S Bennett, A McCluskey, L Tooth, T Hoffmann, K McKenna
[P08-74] Implementation of ‘Risk of bias’ (RoB) tables and ‘Summary of findings’ (SoF) tables in Cochrane reviews: a pilot study Abstract
S Pregno, AD Oxman
[P08-75] Hypericum perforatum for depression: a meta-analysis Abstract
J Gagnier, J Beyene
[P08-76] Transparency of clinical trial in China: strategy and foresight Abstract
X Yang, Q Zhuo, X Zeng, Y Yuan, T Wu
[P08-77] Bias associated with inadequate or unclear concealment of allocation in randomized osteoarthritis trials Abstract
E Nüesch, S Reichenbach, S Trelle, A Rutjes, E Bürgi, M Scherrer, P Jüni
[P08-78] Evaluating risk of bias using prevalence-question systematic review as a model Abstract
A Rajic, B Wilhelm, I Young, L Waddell, S Parker, S McEwen
[P08-79] Overestimation of treatment effects associated with small sample size in osteoarthritis research Abstract
P Jüni, E Nüesch, S Reichenbach, A Rutjes, M Scherrer, E Bürgi, S Trelle
[P08-80] Could do better? Search methods in recent oral health systematic reviews Abstract
FM Morgan, RL Turley, BL Chadwick
[P08-81] Assessing the effects of diagnostic tests on patient outcomes: how reliable, informative and practical are randomised controlled trials? Abstract
LFerrante DiRuffano, J Dinnes, CJ Hyde, JJ Deeks
[P08-82] Identification and authentication of claimed RCTs for Cochrane systematic review Abstract
Q Zhuo, TX Wu, XZ Yang, XX Zeng, Y Yuan
[P08-83] Identification and characterization of systematic reviews in HIV/AIDS Abstract
E Pienaar, N Siegfried
[P08-84] Developing a database structure for meta-epidemiological research Abstract images
J Savovic, The Brando Collaborators
[P08-85] Brazilian oral health journals in Scielo: an open access tropical treasure? Abstract
RF De Souza, CAL Chaves, M Nasser, Z Fedorowicz
[P08-86] Do reviewers and editors detect inadequate descriptions of treatments? Abstract
S Schroter, P Glasziou, C Heneghan
[P08-87] Interpreting intergroup differences on low quality data of adverse events (AE) in primary clinical trials of non-drug interventions Abstract
K Biester, G Skipka, S Lange
[P08-88] Assessment of the Cochrane ‘Risk of bias’ tool: a pilot study Abstract
S Norris
[P08-89] The effect of treatment integrity on the interpretation of its efficacy: a case study of motivational interviewing Abstract
D Lai, J Tang
[P09-90] Evaluation of race, ethnicity, and income in systematic reviews used to develop drug formularies for state-provided healthcare Abstract
DH Odierna, LA Bero
[P09-91] Incorporating relevant evidence into cost-effectiveness analysis Abstract
G Richardson, N Hawkins, A Sutton
[P10-92] Should systematic reviews of diagnostic tests go beyond test accuracy? Abstract
M Westwood, P Whiting
[P10-93] The Alcohol Use Disorders Identification Test’s brief vs. full version for unhealthy alcohol use: a comparative diagnostic accuracy metaanalysis using the difference in area under the receiver operating characteristics curve as effect measure Abstract
L Kriston, L Hölzel, A-K Weiser, MM Berner, M Härter
[P10-94] Assessing the quality of diagnostic studies that use psychometric instruments: applying QUADAS in a novel area Abstract
R Mann, C Hewitt, S Gilbody
[P10-95] Quality assessment of studies for double-reading (DR) of screening mammograms and breast-ultrasound (BU) after negative screening-mammogram: contribution of the QUADAS (Quality Assessment of Diagnostic Accuracy Studies) tool Abstract
M Nothacker, S Weinbrenner
[P11-96] Incorporation of non-randomised evidence in systematic reviews of surgical interventions: a case study of endovascular versus open repair of abdominal aortic aneurysms Abstract
D Fayter, D Chambers, F Paton, K Wright, N Woolacott
[P11-97] Observation or evidence? Are non-randomized studies really more generalizable than randomized trials? Abstract
N Lee, M McDonagh, B Chan
[P11-98] Should Cochrane reviews that include full text reports of nonrandomised evidence also include abstracts of such evidence? Abstract
G Mowatt, F Campbell, JM Burr
[P11-99] Quantification of bias in the results of non-randomised studies compared with randomised studies Abstract images
R Beynon, J Savovic, R Harris, D Altman, J Sterne, J Deeks
[P11-100] A systematic review of studies that determine which outcomes should be measured in clinical trials in children Abstract
I Sinha, L Jones, R Smyth, P Williamson
[P11-101] Observational studies in systematic reviews of comparative effectiveness Abstract
SL Norris, W Bruening, E Johnson, S Fox, R Kane, SC Morton, M Oremus, M Ospina
[P11-102] Combining effect sizes from controlled and uncontrolled study designs: benefit, bias, and control strategies Abstract
Y Nestoriuc, A Martin, W Rief
[P11-103] Adequate adjustment for confounders is vital for a valid interpretation of meta-analyses incorporating non-randomized studies Abstract
C Schmoor, M Schumacher
[P12-104] Patient-based medicine: a useful expansion of evidence-based medicine Abstract
R Rohrbacher, P Marx, T Schaufler, H Schneider
[P12-105] The methodological soundness of literature reviews addressing three potential zoonotic public health issues Abstract
L Waddell, A Rajic´, J Sargeant, S Parker, A Deckert, S McEwen
[P12-106] A systematic approach to identifying and responding to policymakers needs in evidence-based veterinary public health - food safety Abstract
S Read, A Rajic´, J Sargeant, L Waddell, A Fazil, F Pollari, J Farber
[P12-107] Evidence-based health care being developed in South Korea Abstract
SM Lee, YK Park, DA Park, HJ Seo, SJ Lee
[P12-108] Beyond synthesis: developing a research program on knowledge translation and exchange Abstract
R Armstrong, E Waters, J Doyle, N Priest, L Willenberg
[P12-109] Discussion on Chengdu essential medicine list by analyzing drug use in primary health institutions Abstract
B Zhou, J Yu, Y Li, W Li, P Tan, X Li, H Li, J Peng
[P12-110] List of Procedures and Events: a new coverage instrument at the Brazilian supplementary health Abstract
AC Rios, J Carvalho, AP Cavalcante, KS Coelho, MF Medeiros, MR Oliveira, CV Rodrigues, R Salvador
[P12-111] Physicians’ willingness to ration health care: a systematic review of survey findings Abstract
D Strech, G Persad, G Marckmann, M Danis
[P12-112] Is the approval status considered in Cochrane reviews of drug therapies? Abstract
R Potthast, T Kaiser, B Wieseler, V Vervölgyi
[P12-113] Strategies in priority setting for practice guideline development Abstract
J Castillo, L Reveiz, J Buendia, M Torres, P Mosquera, D Tellez
[P13-114] Obstacles to evidence-based practice in Belgium (Flanders): a context-specific synthesis of qualitative research findings Abstract
K Hannes
[P13-115] A synopsis of four Cochrane systematic reviews on bladder training and voiding programmes using metastudy techniques for qualitative research Abstract
B Roe, J Ostaszkiewicz, J Milne, S Wallace
[P13-116] Two reviews are better than one? Developing linkages between a Cochrane review and a review of mixed methods Abstract
R Ryan, D Lowe, M Prictor, S Hill
[P13-117] Using meta-study to synthesize the results of qualitative research: the role of theory Abstract
R Garside
[P13-118] Developing a deeper understanding of the impacts of lay health worker interventions: combining systematic reviews of effectiveness and cost-effectiveness with a realist review of programme theory Abstract
S Lewin, C Glenton, D Walker, A Corluka, I Scheel
[P14-119] Peer-review publication of a new drug technology following initial appearance at a large hematology conference: implications for patients, clinicians, researchers and policy-makers Abstract
ME Kho, MC Brouwers
[P14-120] The need for better design and reporting of RCTs in a neglected but widespread skin disease Abstract
U Gonzalez, M Pinart, L Reveiz, J Alvar
[P14-121] Ambiguity of study population analysis and reporting in asthma clinical trials Abstract images
GK Frampton, J Shepherd
[P14-122] Outcome measurement in clinical trials of pediatric acute diarrhea: a systematic review Abstract
BC Johnston, L Shamseer, BR Da Costa, K Thorlund, S Vohra
[P14-123] Measuring and reporting adherence to exercise for chronic musculoskeletal pain in randomised controlled trials: observations from a Cochrane review Abstract
JL Jordan, MA Holden, EEJ Mason, NE Foster
[P14-124] Updating systematic reviews: an international survey Abstract
C Garritty, AC Tricco, A Tsertsvadze, M Sampson, D Moher
[P14-125] Time to publication of Cochrane reviews: a retrospective cohort study Abstract
AC Tricco, D Moher, MH Chen, R Daniel
[P14-126] The effect of study sponsorship on a systematically evaluated body of evidence was modest: secondary analysis of a systematic review Abstract
G Gartlehner, L Morgan, P Thieda, A Fleg
[P14-127] Systematic review of the empirical evidence of study publication bias and outcome reporting bias Abstract
K Dwan, DG Altman, AW Chan, E Decullier, E Von Elm, C Gamble, JPA Ioannidis, PR Williamson1
[P14-128] Understanding the impact of outcome reporting bias in trials (the ORBIT study) Abstract
K Dwan, DG Altman, S Dodd, C Gamble, A Jacoby, J Kirkham, S Taylor, PR Williamson
[P14-129] The quality of reporting of randomized controlled trials abstracts is sub-optimal: a survey of four major general medical journals Abstract
O Berwanger, RA Ribeiro, A Finkelsztejn, M Watanabe, EA Suzumura, BB Duncan, PJ Devereaux, D Cook
[P14-130] Paediatric RCTs and CCTs: an analysis of trends over time from 1948 to 2006 Abstract
D Thomson, L Tjosvold, B Vandermeer, TP Klassen, L Hartling
[P14-131] Evidence in the ‘‘instructions for authors’’ of surgical journals and their statistical requirements: a descriptive review of 70 leading surgical journals Abstract
F Herrle, C Kreuzberg, S Sauerland, M Niedergethmann, S Post, A Stang
[P14-132] Chinese authors do need CONSORT: reporting quality for five leading Chinese medical journals Abstract
J Li, L Xu, MM Zhang, CL Ai, L Wang
[P14-133] Assessment of the methodological quality of reporting of randomized trials in Iranian dental journals Abstract
M Mahdian, M Nasser
[P15-134] Deworming children to improve growth and school performance: evidence update on a global health policy Abstract
P Garner, D Taylor-Robinson, A Jones
[P15-135] Growth of Cochrane activity and evidence-based practice in Malaysia: the impact of the SEA-ORCHID project Abstract
JJ Ho, A Sivasangari, RP Japaraj, H Van Rostenberghe, ASM Chang, SJ McDonald
[P15-136] The PAHO report on the Venezuelan primary health care intervention Barrio Adentro Abstract
S Vivas-Martinez, ME Martinez, WG Metzger
[P16-137] Developing a sensitive search strategy in Farsi for retrieving reports of randomized trials in Iranmedex Abstract
M Shahiri, M Nasser, H Javaheri
[P16-138] Establishing database of RCT reports published in Chinese with English citation and PICO to support Cochrane reviewers within the Collaboration Abstract
MM Zhang, YP Li, J Li, GJ Liu, W Phil, M Fento
[P16-139] Utilization of online database for medical information: a nationwide survey of physicians at regional hospitals in Taiwan Abstract
KN Kuo, YWB Chiu, HL Lo, YH Shih, HW Ting, YH Weng
[P16-140] Assessment of the validity of a resources-saving selection procedure for non-English studies in systematic reviews Abstract
J Kreis, YB Schueler, D Eyding, B Wieseler
[P16-141] Evaluating the effectiveness of search strategies for systematic reviews in zoonotic public health Abstract
L Waddell, V Nguyen, J Harris, A Rajic
[P16-142] Introducing biomedical databases in China Abstract images
Y Li, Y Chen, L Du, C Ai
[P16-143] Searching LILACS database is irrelevant in systematic reviews in oncology Abstract
A Sasse, L Santos
[P16-144] Numbers of randomized controlled trials reported in Japanese literature database Abstract
T Naito, M Yoneda, N Suzuki, T Hirofuji
[P16-145] The usefulness of The Cochrane Library in the development of a systematic bibliography on employee health and work performance Abstract
JL Jordan, G Wynne-Jones, DAWM VanDerWindt
[P16-146] Where to identify information on adverse effects for a systematic review: a methodological overview Abstract
S Golder, YK Loke, J Burch
[P16-147] Development of the Dementia and Cognitive Improvement Group Specialized Register Abstract
H Collins, A Noel-Storr1
[P16-148] Accessing the evidence: a search portal and reference site for clinical trials in children Abstract
J Wong, D Ghersi
[P16-149] Why were they missed? Randomized controlled trials (RCTs) identified through the MEDLINE Retagging Project but not the US National Library of Medicine (NLM) Abstract images
S Wieland, K Dickersin
[P16-150] Focus EMTREE terms vs. Non-focused EMTREE terms to search for clinical drug trials in EMBASE Abstract
E Hausner, M Simon, T Kaiser
[P16-151] Developing a search filter for ‘upstream’ public health interventions Abstract
J Kavanagh, C Stansfield, T Lorenc, A Harden, A Weightman, J Doyle, E Waters
[P16-152] Developing a child health trials register: benefits, challenges, and solutions Abstract
TP Klassen, L Tjosvold, L Hartling
[P16-153] Comparison of evidence-based answer retrieval from four bedside information sources: a randomized controlled trial Abstract
SF Ahmadi, M Faghankhani, M Akbarshahi, A Javanbakht, M Mirghorbani, B Safarnejad, H Baradaran1
[P16-154] Carnival time: a mapping exercise of Brazilian oral health journals Abstract
MA Marchesan, RF De Souza, T Pereira-Cenci, Z Fedorowicz
[P16-155] The Master List of Journals Being Searched: where it’s been and where it’s going Abstract
R Scherer, K Robinson, K Dickersin
[P16-156] Development of search strategies for retrieving studies on the accuracy of signs and symptoms Abstract
N Shaikh, RG Badgett, AM Ketchum, NL Wilczynski, KA McKibbon, RB Haynes
[P16-157] Optimizing literature searches: a topic-related ‘bottom-ceilingapproach’ Abstract
C Niederstadt, S Droste, M Lelgemann
[P16-158] The value of searching multiple databases for guideline development Abstract
J Kelly
[P17-159] The data extraction challenge: observer variation when extracting data for the calculation of a standardised mean difference Abstract
B Tendal, P Jüni, JPT Higgins, A Hrobjartsson, A Jørgensen, S Trelle, S Wandel, E Nüesch, K Gesser, S Ilsøe-Kristensen, PC Gøtzsche
[P17-160] Empiric comparison of ratio and difference methods for analysing continuous outcomes in meta-analysis Abstract images
JO Friedrich, NKJ Adhikari, R Pinto, J Beyene
[P17-161] Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation Abstract
NA Patsopoulos, E Evangelou, JPA Ioannidis
[P17-162] Reasons or excuses for avoiding meta-analysis in forest plots Abstract
NA Patsopoulos, JPA Ioannidis, HR Rothstein
[P17-163] Incorporating uncertainty of between-trial variance estimates increases the reliability of random-effects meta-analysis Abstract
K Thorlund, J Wetterslev, C Gluud
[P17-164] Methodological and reporting quality of indirect comparisons Abstract
S Donegan, C Tudur-Smith, C Gamble, P Williamson
[P17-165] Comparing atypical antipsychotic agents using mixed treatment comparisons meta-regression Abstract
BK Chan, R Fu, K Peterson, S Carson, S Thakurta, MS McDonagh
[P17-166] Graphs in meta-analysis: worth more than a thousand words? Abstract
L Bax, N Fukui, Y Yaju, H Tsuruta, N Ikeda, T Satoh, KGM Moons
[P17-167] Developing clinically meaningful criteria of ‘response’ that can be used as standards in systematic reviews by equipercentile linking Abstract
S Leucht, R Engel
[P17-168] Prioritising the updating of systematic reviews Abstract
Y Takwoingi, AJ Sutton, S Donegan, P Garner, C Gamble, A Donald
[P17-169] Combining multiple imputation and Bayesian model selection to reduce inconsistency in multiple treatment meta-analysis Abstract
K Thorlund, R Steele, R Platt, J Carlisle, I Shrier
[P17-170] Comparison of Copas selection model for publication bias and trimand-fill Abstract
G Schwarzer, G Rücker, JR Carpenter
[P17-171] Adjusting for publication bias: a multiple imputation approach Abstract
J Carpenter, G Rücker, G Schwarzer
[P18-172] International activity within Cochrane Review Groups Abstract
C Allen, M Clarke, D Wyatt
[P18-173] Comparison of the priority action areas in oral health with the evidence available in The Cochrane Library Abstract
M Nasser, Z Fedorowicz, H Bastian
[P18-174] Dissemination of evidence-based health care in Brazil: use of television programme Abstract
R Riera, RB Andriolo, LGS Lima, CR Macedo, MES Puga, BNG Silva, VP Vieira, AN Atallah
[P18-175] Contextual heterogeneity: unlocking local relevance from global evidence Abstract
R Gruen, S Green, J Lavis
[P18-176] Extending and strengthening the end-user perspective in The Cochrane Collaboration Abstract
C Cattivera, R De Souza, J Wale
[P18-177] The Cochrane Library: usage statistics and trends on Wiley Inter-Science - the who, where and what Abstract
F Reynolds
[P18-178] Information concerning the safety and adverse effects of medical procedures reported in a Brazilian journal Abstract
R Riera, VP Vieira, RB Andriolo, LG Lima, CR Macedo, MES Puga, BN Silva, AN Atallah
[P18-179] How global is our knowledge? Population diversity in observational studies on selenium and cancer risk Abstract
G Dennert, M Brinkmann, M Vinceti, M Zeegers, M Zwahlen, M Horneber
[NN-01] Lack of access to unpublished clinical study reports and trial protocols at drug agencies, and lack of good arguments against access Abstract
PC Gøtzsche
[NN-02] Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal "instructions to authors" Abstract
S Hopewell , DG Altman , D Moher , KF Schulz
[NN-03] Sociological perspective Abstract
RE Aldred
[NN-04] Options for presenting results of continuous variables in "Summary of findings" tables images
G Guyatt , PJ Karanicolas , A Oxman , D Patrick , H Schunemann
[NN-05] Fixed and random effect models when one trial dominates metaanalysis results Abstract images
G Guyatt , PJ Devereaux , J Pogue , S Yusuf , H Yang , V Montori , P Alonso-Coello , G Urrutia , O Berwanger , A Ciapponi , A Salazar , M Tristan

Workshop presentations

W01 - Reaching the end users through effective and safe patient-centred health care - what CCNet can provide Abstract
Janet Wale, Silvana Simi, Sara Yaron, Anne Lyddiatt
W02 - When rating gets tough - coping with difficult situations when using the new risk of bias assessment tool Abstract
Klaus Linde, Sven Trelle, Peter Jueni
W03 - Ensuring relevance and building enthusiasm for Cochrane reviews: determining appropriate methods for identifying priority topics for future Cochrane reviews Abstract
Mona Nasser, Peter Tugwell, Vivian Welch, Erin Morris, Elizabeth Waters, Jodie Doyle
W04 - Systematic reviews of diagnostic accuracy studies. 2: assessment of methodological quality Abstract
Penny Whiting, Anne Rutjes, Mariska Leeflang, Vasiliy Vlassov, Hans Reitsma
W05 - Systematic reviews of diagnostic accuracy studies 1: Formulating the study question and identification of studies Abstract
Graziella Filippini, Patrick Bossuyt, Roberto D'Amico, Ruth Mitchell
W06 - PEARLS - short summaries of evidence enthusiastically received Abstract
Tim Kenealy, Floris van de Laar
W07 - RevMan 5 presentation for Cochrane Intervention review authors Abstract
Elizabeth Pienaar, Mona Nasser, Kate Cahill
W08 - Archie training for Cochrane Review Group (CRG) editors Abstract
Sonja Henderson, Liz Dooley
W09 - Study-based Registers Abstract
Gail Higgins, Lynn Hampson, Hugh McGuire
W10 - Developing Summary of Findings (SoF) tables for Cochrane reviews Abstract
Holger Schunemann
W11 - Developing a fictitious review as a training resource for Cochrane authors Abstract
Miranda Cumpston, Veronica Pitt, Denise O'Connor, Sarah Hetrick, Steve McDonald
W12 - The Cochrane Library:hands-on searching (advanced) Abstract
Laura Sampson
W13 - Non-inferiority in Clinical Trials: Biometrical and Regulatory Aspects / Non-inferiority with Meta-Analyses Abstract
Dieter Hauschke, Stefan Witte
W14 - How to include economics in Cochrane review protocols. Part 1: background, study questions, outcome measures and types of studies Abstract
Ian Shemilt
W15 - Economics and equity in health care: current perspectives and evidence Abstract
Erin Morris, Miranda Mugford, Peter Tugwell, David McDaid, Damian Walker, Helen Weatherly, Elizabeth Kristjansson
W16 - Cochrane-based decision support: global evidence at the point of care Abstract
Ilkka Kunnamo, Peter Nyberg
W17 - Methods for synthesizing & integrating qualitative evidence Abstract
Jane Noyes
W18 - A guide to prospective meta-analysis Abstract
Lisa Askie, Davina Ghersi
W19 - Introductory/intermediate workshop for Cochrane Trials Search Co-ordinators Abstract
Carol Lefebvre
W20 - The role of meta-regression in Cochrane reviews Abstract
Judith Anzures, Georgia Salanti
W21 - Dealing with heterogeneity Abstract
Gerogia Salanti
W22 - Basics of meta-analysis Abstract
Steff Lewis
W23 - Introduction to meta-analysis of continuous outcomes Abstract
Peter Jueni
W24 - Guidelines for end-user peer review of Cochrane reviews and protocols - with a view to clinical guidelines Abstract
Janet Wale, Kathie Godfrey, Amy Zelmer, U Hla Htay
W25 - Systematic reviews of diagnostic accuracy studies 3: A practical introduction to meta-analysis Abstract
Jon Deeks, Rob Scholten, Mariska Leeflang
W26 - Advanced meta-analysis of diagnostic test performance: investigating heterogeneity and comparing tests Abstract
Petra Macaskill, Roger Harbord
W27 - Disseminating the findings of systematic reviews: the CRD approach Abstract
Paul Wilson, Alison Booth
W28 - The Cochrane Updating Project: Lessons learnt and ways forward Abstract
Julie Brown, Anne Lethaby, Jane Clarke, Vanessa Jordan, Marian Showell, Cindy Farqhuar
W29 - RevMan 5 for Cochrane Intervention review authors - learn to use all the features hands-on. Abstract
Elizabeth Pienaar, Kate Cahill, Monica Kjeldstrom, Mona Nasser
W30 - Using workflows in Archie Abstract
Monica Kjeldstrom, Liz Dooley, Kate Cahill, Sonja Henderson, Becky Gray, Karen Hovhannisyan
W31 - Register & handsearch submissions for CENTRAL: all you need is trials! Abstract
Gail Higgins
W32 - Working with the GRADEprofiler (GRADEpro) Abstract
Holger Schunemann
W33 - Navigating The Cochrane Library Abstract
Laura Sampson, Nigel Thompson, Fabienne Reynolds
W34 - Statistical methods for meta-analysis: an overview Abstract
Joseph Beyene
W35 - How to include economics in Cochrane review protocols. Part 2: search methods, critical appraisal, data collection and analysis Abstract
Ian Shemilt
W36 - Use of Field Topic Lists in Archie Abstract
Eric Manheimer, Susan Wieland
W37 - Systematic Reviews of Prognosis Studies: From Protocol to Meta-analysis Abstract
Katrina Williams, Doug Altman, Rieke de Vet, Richard Riley, Jill Hayden, Susan Woolfenden
W38 - Extracting data for a systematic review of non-randomised studies (NRS) of a public health intervention Abstract
Barney Reeves, George Wells
W39 - Calculation and interpretation of the number needed to treat (NNT) Abstract
Ralf Bender, Mandy Hildebrandt
W40 - Identifying and assessing the impact of outcome reporting bias in meta-analysis Abstract
Jamie Kirkham, Paula Williamson, Kerry Dwan, Doug Altman
W41 - How to handsearch paper and electronic journals and conference proceedings to identify articles eligible for the Cochrane CENTRAL Register of Controlled Clinical Trials Abstract
Roberta Scherer, Ruth Mitchell
W42 - Advanced workshop for Cochrane Trials Search Co-ordinators (closed) Abstract
Carol Lefebvre
W43 - Including non-standard studies and non-standard data in a meta-analysis Abstract
Judith Anzures
W44 - Estimating hazard ratios using Parmar's methods Abstract
Heather Dickinson, Andrew Bryant
W45 - Multiple-treatments meta-analysis: challenges and opportunities Abstract
Georgia Salanti, Peter Jueni, Deborah Caldwell
W46 - Statistical methods for meta-analysis of individual patient data Abstract
Richard Riley, Christopher Schmid, Paula Williamson
W47 - Investigating and dealing with bias in systematic reviews Abstract
Jonathan Sterne, David Moher, Peter Jueni
W48 - A Roadmap to Success: Strategic Planning and Performance Measurement for Entity and Organisation Administrators Abstract
Mary Ellen Schaafsma
W49 - Consumers speak out! What do we want results reporting to look like? Abstract
Kay Dickersin, Janet Wale, Davina Ghersi
W50 - How to search for studies for inclusion in Cochrane diagnostic test accuracy reviews Abstract
Ruth Mitchell, Anne Eisinga, Marie Westwood
W51 - Grading the quality of evidence and preparing summary of findings tables for diagnostic tests Abstract
Holger Schunemann, Andrew Oxman, Gordon Guyatt, Nancy Santesso, Jan Brozek
W52 - Systematic reviews of diagnostic accuracy studies 5: presenting and interpreting results Abstract
Rob Scholten, Chris Hyde
W53 - Tools and resources for reviews of complex interventions: a workshop by the Consumers and Communication Review Group Abstract
Megan Prictor
W54 - Publication ethics and Cochrane reviews Abstract
Laura Sampson, Liz Wager, Suzan Fiack
W55 - Using the new Cochrane Style Guide Abstract
Nancy Owens, Harriet MacLehose
W56 - Advanced EPOC Methods Workshop Abstract
Russell Gruen, Emma Tavender, Gro Jamtvedt, Doris T Kristoffersen
W57 - Who wants to be a meta-analyst: The Second Annual Game Show Edition Abstract
Ian Shrier, Julian Higgins, Joseph Beyene, Kristian Thorlund
W58 - Cochrane SoF Tables "train the trainers" workshop Abstract
Holger Schunemann, Nancy Santesso, Andrew Oxman, Gordon Guyatt, Jan Brozek
W59 - Cochrane Podcasting for Dummies Abstract
Laura Sampson, Chris Mavergames, Mike Clarke, Deborah Pentesco-Gilbert
W60 - Train the trainers of evidence-based healthcare workshops Abstract
S. Swaroop Vedula, Roberta Scherer, Phil Wiffen, Elizabeth Pienaar, Joseph Mathew
W61 - Interpretation of PROS in Cochrane Reviews Abstract
Donald Patrick, Gordon Guyatt
W62 - RevMan 5 for Cochrane Diagnostic test accuracy reviews Abstract
Mariska Leeflang, Tess Moore, Rasmus Moustgaard, Lotty Hooft
W63 - Searching for, retrieving and incorporating adverse effects data Abstract
Su Golder, Andrew Herxheimer
W64 - The development of the new Cochrane Register of Controlled Studies Abstract
Ruth Foxlee
W65 - Identifying Qualitative Research to complement Cochrane Reviews Abstract
Andrew Booth
W66 - Searching for studies Abstract
Bernadette Coles, Carol Lefebvre, Alison Weightman, Jessie McGowan
W67 - Reviews with survival from cancer as the primary outcome: writing the protocol Abstract
Heather Dickinson, Andrew Bryant, Anne Oestmann, Clare Jess, Gail Quinn, Jane Hayes
W68 - Meta-analysis of continuous outcomes: helping review authors negotiate the change score versus final value debate
Joanne McKenzie, Doug Altman
W69 - Testing for differences in effect between subgroups: Time for a rethink? Abstract
Roger Harbord, Julian Higgins
W70 - Missing data in meta-analysis - a practical guide Abstract
James Carpenter
W71 - Assessing risk of bias in included studies: the recommended tool for Cochrane reviews Abstract
Julian Higgins, Joel Gagnier
W72 - Grading the quality of evidence in concise evidence summaries: experience from EBM Guidelines Abstract
Jukkapekka Jousimaa, Helena Varonen
W73 - Kritische Beurteilung wissenschaftlicher Texte für Verbraucher/innen - Critical Appraisal Skills' for Consumers (in German) Abstract
Sascha Köpke, Martina Bunge
W74 - Methods for measuring the patient's perspective in Evidence-based Medicine Abstract
John Bridges
W75 - Making sense of scientific evidence: a workshop for consumers Abstract
Gill Gyte